CSI Market
Sign In | Register

Taysha Gene Therapies Inc (TSHA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TSHA Annual Balance Sheets →
Examining balance sheet movements between Taysha Gene Therapies Inc and Sep 30 2025 reveals how Sep 30 2026 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TSHA/balance-sheets
https://api.csimarket.com/api/v1/companies/TSHA/fundamentals
https://api.csimarket.com/api/v1/companies/TSHA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent422.83
Restricted Cash0.17
Cash & Short-term Investments422.00
Deferred Offering Costs DE0.11
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.24
Total Current Assets426.06
Equipment/Property/Plant Net7.66
Other Assets, Noncurrent1.32
Operating Lease Right Of Use Asset9.16
Total Assets435.03
Liabilities
Accounts Payable, Current AC5.59
Accrued Liabilities And Other Liabilities7.72
Other Liabilities, Current9.64
Deferred Revenue, Current DE0.00
Total Current Liabilities22.95
Long-term debt47.33
Total Long-term Debt47.33
Other liabilities, Noncurrent7.78
Operating Lease Liability Noncurrent17.77
Total Liabilities78.06
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,194.10
Retained Earnings / Accumulated Deficit-839.48
Accumulated Other Comprehensive Income2.35
Other Equity2.35
Common Stockholder's Equity356.97
Total Stockholder's Equity356.97
Liabilities & Stockholder's Equity435.03
4 historic quarters locked

Sign in to unlock the full Taysha Gene Therapies Inc balance sheet history.

Sign In Create Free Account

About Taysha Gene Therapies Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 12, 2026
  • Source: tsha-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-456949

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI